Effects of recombinant human granulocyte/macrophage colony-stimulating factor on diabetic lower extremity ulcers: Case series of nine patients
SALDY YUSUF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 17, 2105β2106
DOI: 10.2147/DMSO.S478219
The study introduces Recombinant Human Granulocyte/Macrophage Colony-Stimulating Factor (rhGM-CSF) to confirm its effects in clinical practice among of nine DFU cases. Despite the authors reporting that 7 out of 9 ulcers had wound size reduction to zero (0 cmΒ²) by day 18, one by day 21, and another by day 24, we note some method-related issues need to be clarified to make it possible to be replicated by other researchers.
First, the authors refer neuropathy to the Carrington Study, as a reduced nerve conduction velocity confirmed by electromyogram and abnormalities in pinprick, vibration perception, pressure perception, and temperature perception.2 The neuropathy data is presented in Table 1 as nominal data (+ or -) but fails to inform which test the authors perform and the diagnostic criteria to confirm neuropathy. We would like to highlight that currently, The International Working Group on..
DOI: 10.2147/DMSO.S478219




